Guangzhou Pharmaceutical and its subsidiary Guangzhou Baiyunshan Pharmaceutical are wholly state-owned companies. Guangzhou Pharmaceutical is principally engaged in research and development, manufacturing and sales of Chinese and western patent medicine, chemically active pharmaceutical ingredients (API), natural medicine, biological medicine and chemical API intermediates; wholesale, retail, import and export of western and Chinese pharmaceutical products and medical devices; research and development, production and sales of healthcare products; and investments in the healthcare industry. It is one of the largest healthcare companies in China.